Dr. Fiona Gilbert from the University of Cambridge discusses the grave threat that the U.K.'s Brexit poses to the future of imaging research, and she also speaks about the persistent controversies in breast cancer screening and the growing potential of digital breast tomosynthesis.
Pre-Info from Phillip Ward (this info is not for unchecked publishing): Breast cancer screening with tomosynthesis: the time is now Prof. Fiona J. Gilbert, Cambridge, U.K.Video from ECR 2017: Dr. Fiona Gilbert on Brexit & breast screening
Mar 1, 2017
Latest in Conference
When AI and radiologists miss the same thing
March 13, 2026
ECR 2026 draws record number of participants to Vienna
March 12, 2026


















